Cure Parkinson's is currently accepting applications for its Quarterly Research Grant for Parkinson’s Disease 2027. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
About Cure Parkinson's - Quarterly Research Grant for Parkinson’s Disease
The programme focuses on funding research that aims to slow, stop, or reverse Parkinson’s disease. Cure Parkinson’s prioritizes projects with a clear path to clinical testing within five years, excluding studies aimed solely at symptomatic relief. Clinical projects must involve individuals with Parkinson’s, rather than healthy volunteers.
Benefits of Cure Parkinson's - Quarterly Research Grant for Parkinson’s Disease
- Preclinical Projects: Funding up to £300,000, with a maximum duration of 36 months.
- Clinical Trials: Grant amounts depend on the trial stage.
- Clinical Infrastructure Projects: Typically funded between £75,000 and £300,000.
- Cost Requirements: Commercial applications must justify costs equivalent to academic standards.
Cure Parkinson's - Quarterly Research Grant for Parkinson’s Disease Requirements
- Academic and commercial entities worldwide.
- Projects must align with Cure Parkinson’s disease modification goals.
- Commercial costs must align with academic standards.
- Budget submissions in GBP are required for non-GBP currencies.
Application Date and Process
- Click on the link to the application website to apply.
Application Deadline
18 January, 2027
Opportunity Application
View details of
Cure Parkinson's - Quarterly Research Grant for Parkinson’s Disease
Apply for Cure Parkinson's - Quarterly Research Grant for Parkinson’s Disease
